Titanium

What is Titanium?

Titanium is element 22, symbol Ti, atomic weight 47.867. The Reverend William Gregor identified it in Cornish black sand in 1791, and Martin Heinrich Klaproth named it in 1795 after the Titans of Greek myth. It is the ninth most abundant element in the Earth's crust at roughly 0.6 percent by weight, it melts at 1,668 degrees Celsius, and its density is 4.50 g/cm3. Nothing in human biochemistry uses it. There is no Recommended Dietary Allowance, no Adequate Intake, no Tolerable Upper Intake Level, and no deficiency state has ever been described in any species. Of 121,959 on-market labels in the NIH Dietary Supplement Label Database, exactly 39 list elemental titanium as an ingredient, almost all of them liquid colloidal or ionic trace mineral products. In the same database, 5,057 on-market labels list titanium dioxide, and not one of them is selling it to you.

Common Names

• Titanium (elemental metal, CAS 7440-32-6)

• Titanium dioxide, TiO2 (CAS 13463-67-7, FDA UNII 15FIX9V2JP)

• E171 in European additive numbering, INS 171 internationally

• CI 77891 in cosmetic and pigment nomenclature

• Titanium white, rutile, anatase, brookite

Primary Active Compounds

• Titanium dioxide, the only form that appears in supplements, used as an opacifier and white colorant in film coatings, capsule shells and printing inks

• Commercially pure titanium metal, ASTM Grades 1 through 4, used in implants

• Ti-6Al-4V, ASTM Grade 5, roughly 6 percent aluminum and 4 percent vanadium, the workhorse orthopedic alloy

• Titanium tetrachloride, TiCl4, an industrial intermediate in the chloride process, corrosive and never present in a finished product

Key Note

Titanium is not a poison in the way mercury, antimony or thallium are poisons, and this issue does not treat it as one. Metallic titanium is close to biologically inert, which is exactly why it makes good bone screws. Titanium dioxide is a poorly soluble particle that mostly passes through the gut. The interesting question is not toxicity in the classical sense. It is why a substance with no benefit to the swallower is in about one in twenty-four American supplement bottles at all, and why the European Union pulled it out of the food supply in 2022 while the United States left it in place.

Everything below treats titanium as what it is on a supplement label: a manufacturing decision, not an ingredient.

Primary Functions & Benefits

Titanium has no function in human physiology, so this section describes what titanium dioxide does for the manufacturer, which is the only thing it does at all.

Opacity. Titanium dioxide has a refractive index of about 2.49 in the anatase form and 2.61 in the rutile form, among the highest of any commonly used white solid. That is the entire mechanism. Particles near half the wavelength of visible light scatter it efficiently, so a thin coating hides whatever is underneath.

Cosmetic uniformity. Vitamin and botanical powders are brown, green, gray or mottled, and they vary batch to batch. A white coating makes 90 tablets in a bottle look identical to each other and to the ones purchased last year.

Photoprotection. Light-sensitive actives including riboflavin, folate, retinol and cyanocobalamin degrade under UV and visible light. An opaque coating slows that. This is a real technical function and the strongest argument the manufacturer has. It is also achievable without titanium dioxide.

Taste and odor masking. A film coat over a bitter or fishy core is easier to swallow, but the polymer film does the masking. Titanium dioxide only makes it white.

Only photoprotection reaches the buyer, and it does so by protecting actives already paid for. The rest serves the shelf.

Forms & Standardization

For a substance with no dietary role, "forms" means chemistry and toxicology rather than bioavailability, so this section covers what each form actually is and where it turns up.

Metallic titanium. Commercially pure titanium, ASTM Grades 1 to 4, differs only in oxygen and iron content. Grade 5, Ti-6Al-4V, adds roughly 6 percent aluminum and 4 percent vanadium and carries most of the load in hips, knees and spinal hardware. It instantly forms a passive TiO2 layer 2 to 6 nanometers thick in air, and that oxide layer is what bone bonds to. This form is never ingested.

Titanium dioxide polymorphs. Rutile is the thermodynamically stable form and dominates paint pigment. Anatase is the form most often used in food and pharmaceutical grades, and is the more photocatalytically active of the two. Brookite is a mineralogical curiosity with no commercial use.

Regulatory specification, United States. 21 CFR 73.575 defines the color additive as synthetically prepared TiO2 free from admixture with other substances, not less than 99.0 percent TiO2 after drying for 3 hours at 105 degrees Celsius. Contaminant ceilings are lead not more than 10 ppm, arsenic not more than 1 ppm, antimony not more than 2 ppm, mercury not more than 1 ppm. Silicon dioxide and aluminum oxide are permitted as dispersing aids up to 2 percent combined. Batches are exempt from FDA certification.

Particle size. EFSA's 2021 assessment reported that fewer than 50 percent of constituent particles by number in E171 have a minimum external dimension below 100 nanometers. Weir and colleagues, measuring food-grade material directly in 2012, put roughly 36 percent of particles below 100 nanometers in at least one dimension. Both figures describe the same awkward fact: E171 is not a nanomaterial by definition, but a large minority of it is nanoscale.

What is not standardized. Nothing about the titanium dioxide in a supplement is disclosed to the buyer. There is no declared amount, no declared particle size, no declared polymorph. A US label lists it by name in the other ingredients line and stops. The Supplement Facts panel, the part with numbers on it, does not mention it, because that panel is reserved for dietary ingredients and titanium dioxide is not one.

Food Sources

Titanium is not a nutrient, so this section covers routes of exposure rather than dietary sources, and the honest headline is that essentially all of it is added rather than grown.

• Confectionery. Weir and colleagues (Environ Sci Technol 2012;46:2242-50) found the highest titanium content in candies, sweets and chewing gums, with coated gum shells and white candy coatings the standouts.

• Supplement and drug coatings. The same study measured titanium in high-consumption pharmaceuticals at between the instrument detection limit of 0.0001 micrograms Ti per milligram of product and a high of 0.014 micrograms per milligram. At the top of that range a 1,000 mg tablet carries roughly 14 micrograms of titanium, about 23 micrograms of TiO2. Coated supplement tablets are built the same way.

• Toothpaste and sunscreen. Toothpastes and some sunscreens measured 1 percent to more than 10 percent titanium by weight. Toothpaste is mostly spat out and sunscreen is topical, but per gram these are far richer sources than any pill.

• Whole foods. No food plant or animal concentrates titanium to a nutritionally or toxicologically meaningful degree. Unlike thallium or cadmium, titanium in the diet is not a soil story. It is a formulation story.

• The European exception. Since 7 August 2022, food sold in the EU is no longer a route of exposure at all, because E171 is not permitted in it. EU medicines still contain it.

Weir's Monte Carlo model put a typical US adult at roughly 1 mg titanium per kilogram body weight per day, with children higher because sweets carry more. For a 70 kg adult that is about 70 mg daily, and almost none of it comes from supplements. The pills are a small share of a mostly confectionery exposure.

Who Should Take Titanium

No one should take titanium. There is no intake at which any benefit has been demonstrated, because there is no benefit to demonstrate.

Who is unavoidably exposed. Anyone taking coated tablets from mainstream American retail. The concentration is not uniform across the market. Among on-market labels in DSLD, titanium dioxide appears on 1,790 of 16,798 tablet products, 10.7 percent, and 892 of 9,957 softgels, 9.0 percent, but only 1,606 of 43,301 capsules, 3.7 percent, and 104 of 24,074 powders, 0.4 percent. Product category matters more than form: 347 of 2,009 multivitamin and mineral labels carry it, 17.3 percent, and 250 of 1,230 single vitamin and mineral products, 20.3 percent, against 271 of 36,274 botanical products, 0.7 percent.

Who should look hardest. People taking prenatal or pregnancy and lactation products. Of 854 on-market labels targeted at pregnant and lactating users, 212 list titanium dioxide, 24.8 percent, the highest proportion of any group measured here.

Who does not need to worry about this at all. Anyone with a titanium implant. That is a different material in a different place doing a different job, covered in section 11.

Who Should AVOID or Use Caution

Contraindications

• There is no medical indication for consuming titanium in any form, so there is nothing to contraindicate. The relevant question is avoidance, not dosing.

• Deliberate ingestion of any titanium product marketed as a mineral supplement has no evidence base whatsoever. The 39 on-market DSLD labels listing elemental titanium, 32 of them liquids, are selling a trace element with no established requirement.

Use Caution

• People with inflammatory bowel disease. The hypothesis is that poorly soluble particles are taken up by Peyer's patches and interact with gut immune tissue. A randomized trial of a low microparticle diet in Crohn's disease showed no benefit over control, so this stays a hypothesis rather than a finding.

• Workers handling titanium dioxide powder. This is the only exposure route with a documented hazard, and it is inhalation, not ingestion.

Critical Safety Point

The real hazard associated with titanium dioxide is respiratory and occupational, and it does not transfer to swallowing a coated tablet. IARC classified titanium dioxide as Group 2B, possibly carcinogenic to humans, in Monograph 93, on the basis of inhalation data in rats. NIOSH set recommended exposure limits of 2.4 mg/m3 for fine titanium dioxide and 0.3 mg/m3 for ultrafine, as time-weighted averages for a 10-hour workday during a 40-hour week, in Current Intelligence Bulletin 63, publication 2011-160. Neither figure is about the diet, and neither should be presented as one.

Recommended Dosages

There is no recommended dosage of titanium, and every number below is a regulatory ceiling or a reference value, not an amount anyone should consume.

United States, color additive limit

• 21 CFR 73.575: titanium dioxide may be used for coloring foods generally, provided the quantity does not exceed 1 percent by weight of the food. This is a maximum permitted concentration, not a target.

International reference value

• JECFA reaffirmed an ADI of "not specified" for INS 171 on 24 November 2023, the same designation it assigned in 1969. In JECFA usage that means the committee saw no reason to set a numerical limit, not that any amount is recommended.

European Union

• E171 was previously permitted at quantum satis in listed food categories, including solid food supplements. As of 7 August 2022 the permitted level in EU food is zero.

EFSA

• No Acceptable Daily Intake could be established in the 2021 opinion. That is not a ceiling of zero and it is not a ceiling of anything. It is the absence of a number.

Duration

There is no duration of use, because there is no use. The only meaningful timeframe is cumulative exposure, and no program tracks it in the general population.

Timing & Administration

Nothing about titanium dioxide is timed, dosed or administered by the buyer, so the practical question is when to look for it rather than when to take it.

Look at the paragraph immediately below the Supplement Facts panel, headed "Other Ingredients." US labeling rules require non-dietary components to be declared there in descending order of predominance, by common name, without amounts. Titanium dioxide will appear as "titanium dioxide," occasionally as "color (titanium dioxide)." On the Spring Valley Calcium, Magnesium & Zinc plus Vitamin D3 label it is twentieth in a list of twenty-three, sitting between sugar and tocopherol.

Two shortcuts. Uncoated tablets and clear or colored gelatin and HPMC capsules mostly do not have it, which is why capsules run 3.7 percent against tablets at 10.7 percent. Gummies almost never do: 13 of 3,007 on-market gummy labels, 0.4 percent.

Timeline of Effects

There is no intended effect, so there is no onset, no peak and no fair trial period. What follows is kinetics.

Absorption. Pele and colleagues (Part Fibre Toxicol 2015;12:26) gave 100 mg of pharmaceutical and food grade anatase titanium dioxide in two 50 mg capsules to healthy volunteers, with blood drawn from seven. Particle signal in blood rose from 2 hours and peaked at about 6 hours, and dark field microscopy showed intact reflectant particles rather than dissolved titanium. Absorption is low, and EFSA put systemic availability at probably not greater than 0.5 percent, but it is not zero.

Accumulation. Heringa and colleagues (Part Fibre Toxicol 2018;15:15) quantified titanium and TiO2 particles in 15 post-mortem human livers and spleens using single-particle ICP high-resolution mass spectrometry. Particles were present in every case, with at least 24 percent of them below 100 nanometers. The measured levels sat below doses regarded as safe in animals, but the authors reported that half were above the level deemed safe for liver damage in humans once conventional uncertainty factors were applied.

Clearance. Slow and poorly characterized. There is no established half-life for particulate titanium dioxide in human liver or spleen, and no clinical intervention shortens it.

Benefits of Taking Titanium

There are no benefits to taking titanium, and there never have been. The genuine titanium success story is surgical, and it deserves to be stated plainly rather than blurred into the supplement question.

Per-Ingvar Brånemark's Swedish group established in the 1960s that bone bonds directly to a titanium surface, a phenomenon he named osseointegration, after finding that titanium optical chambers implanted in rabbit bone could not be removed. That observation became the modern dental implant. Howe, Keys and Richards (J Dent 2019;84:9-21) pooled 18 studies and reported 10-year implant-level survival of 96.4 percent, 95 percent CI 95.2 to 97.5, falling to 93.2 percent, 95 percent CI 90.1 to 95.8, in a sensitivity analysis accounting for missing follow-up. Orthopedic titanium has a comparably long record.

Two things make that record possible, and both are the opposite of a nutritional claim. Titanium is inert, so the body does not metabolize it, and the passive oxide film on its surface is chemically stable, so it does not corrode into circulation the way some earlier implant alloys did. A titanium hip and a titanium dioxide tablet coating share an element and nothing else. Confusing them in either direction, treating implant safety as evidence that the excipient is fine, or treating the additive controversy as a reason to fear implants, is the commonest error in writing about this element.

Potential Negatives & Side Effects

Titanium dioxide in a coated tablet produces no recognized acute side effects, and the honest summary is that the case against it is about unresolved questions rather than observed harm.

• No documented acute oral toxicity syndrome. There is no clinical picture of titanium dioxide poisoning from food or supplements. No case reports, no poison center syndrome, no antidote, because none is needed.

• Unresolved genotoxicity question. EFSA reported that titanium dioxide particles have the potential to induce DNA strand breaks and chromosomal damage but not gene mutations, and concluded that a concern for genotoxicity could not be ruled out. That is a statement about missing reassurance, not about observed disease.

• Immune and intestinal effects in rodents, contested. Bettini and colleagues (Sci Rep 2017;7:40373) gave rats 200 micrograms per kilogram and 10 mg per kilogram body weight per day of E171 in drinking water for 100 days, 11 to 12 animals per group, and reported more aberrant crypts and large aberrant crypt foci at the higher dose, with about 36 percent of exposed animals developing preneoplastic lesions with no chemical initiator. Blevins and colleagues (Food Chem Toxicol 2019;133:110793) fed male Wistar Han rats E171 at 0, 40, 400 and 5,000 ppm in the diet for 7 or 100 days, 16 animals per group in the 100-day arm, and found no effect on immune parameters, tissue morphology, aberrant crypt foci, goblet cell numbers or colonic gland length. Same additive, different route, different result.

• Contaminant load, small but real. Food-grade titanium dioxide is allowed up to 10 ppm lead, 1 ppm arsenic, 2 ppm antimony and 1 ppm mercury under 21 CFR 73.575. At the microgram quantities in a coating this is negligible arithmetic, but it is a nonzero addition to a total-diet burden a buyer gets nothing for.

Deficiency Symptoms

There is no titanium deficiency, because titanium has no biological function to be deficient in. No enzyme requires it, no transport protein carries it, no genetic disorder of titanium handling exists, and no animal has ever been made titanium-deficient under experimental conditions.

What titanium addresses

Nothing. This is not a case of thin evidence. It is a case of no proposed mechanism. Compare a genuine trace element: molybdenum has an RDA of 45 micrograms per day for adults and a defined cofactor role in sulfite oxidase, xanthine oxidase and aldehyde oxidase, and human molybdenum cofactor deficiency is a described, lethal metabolic disease. Selenium has an RDA of 55 micrograms per day and a defined role in 25 selenoproteins. Titanium has none of that infrastructure.

Bottom line

Any product marketing titanium as a needed trace mineral is selling a requirement that does not exist. Thirty-nine on-market labels do exactly that.

Toxicity Symptoms

Titanium dioxide is not acutely toxic by mouth, and this section describes hazards that exist by other routes rather than an oral poisoning syndrome.

At high intake

Oral acute toxicity is very low. Rodent oral LD50 values are conventionally reported as greater than 5,000 mg per kilogram body weight, and studies EFSA reviewed found no adverse effects with E171 up to 1,000 mg per kilogram body weight per day, including an extended one-generation study that found no reproductive or developmental effects at that dose. The concern EFSA raised was not about a dose producing symptoms. It was about genotoxicity, for which no threshold can be assumed.

Signs to reduce or stop

There is no recognized clinical sign of excess dietary titanium dioxide, and no clinical test is validated for it in the general population. Serum and urine titanium testing exists for implant surveillance in orthopedics and has no established role for dietary exposure.

General note

The documented hazard is inhalation of respirable powder in industrial settings. IARC placed titanium dioxide in Group 2B on that basis. The EU went further and classified it as a Category 2 carcinogen by inhalation, H351, through Commission Delegated Regulation (EU) 2020/217, applicable from 1 October 2021. The EU General Court annulled that classification on 23 November 2022, and the Court of Justice dismissed the Commission's appeals in joined cases C-71/23 P and C-82/23 P on 1 August 2025, finding that the risk assessment had failed to account for all relevant factors in evaluating the underlying study. The inhalation classification is therefore no longer in force in the EU, while the food additive ban is. Two separate legal tracks, moving in opposite directions.

How Titanium Works

Titanium dioxide works optically in the tablet and, so far as anyone can demonstrate, does nothing at all in the person.

The optical mechanism. Opacity comes from refractive index contrast. Titanium dioxide sits at about 2.49 for anatase and 2.61 for rutile against roughly 1.5 for the polymer film holding it, and that mismatch scatters light strongly. Scattering peaks when particle diameter is near half the wavelength of visible light, around 200 to 300 nanometers, which is why pigment grades are milled to that range rather than made as small as possible. Formulation studies have run it at 40 percent of the coating pigment load with weight gains of 5 to 8 percent of tablet weight to hide a strongly colored core.

Why it mostly does not work biologically. Titanium dioxide is a poorly soluble, poorly absorbed particle. It does not dissociate into a bioavailable ion the way zinc sulfate or ferrous fumarate do. EFSA estimated oral systemic availability at probably not greater than 0.5 percent, and Pele's volunteer study detected intact particles in blood rather than dissolved titanium. The overwhelming majority passes through the gut and leaves in the feces.

Where the scientific dispute actually sits. Both EFSA and FDA agree the particles are poorly absorbed. The disagreement is about what the small absorbed fraction does. Direct genotoxicity would mean the particle itself damages DNA. Secondary genotoxicity would mean particles provoke inflammation and reactive oxygen species, which then damage DNA, and that pathway would have a threshold below which nothing happens. EFSA declined to assume the mechanism was secondary and therefore declined to assume a threshold existed. FDA, reviewing the same body of work, concluded the data did not show a direct DNA-damaging mechanism. Neither agency claims titanium dioxide has been shown to cause cancer in people.

Synergistic Supplements

Nothing works synergistically with titanium dioxide, because it has no biological activity to be enhanced.

In formulation it travels with a predictable set of co-excipients rather than nutrients. On the Spring Valley label cited above, titanium dioxide appears alongside talc, silica, carnauba wax, hydroxypropyl methylcellulose, triethyl citrate, croscarmellose sodium, polysorbate 80 and magnesium stearate. Those are the plasticizers, film formers, glidants and polishing agents that make a coated tablet, and they are the company a buyer should expect it to keep. Seeing titanium dioxide is a reliable signal that a tablet is film-coated, and nothing more.

Interactions & What NOT to Take

Titanium dioxide has no documented pharmacokinetic drug interactions at the microgram quantities present in a tablet coating, and the useful information here is about what has and has not been looked for.

• No CYP450 involvement. Titanium dioxide is not metabolized and does not induce or inhibit hepatic drug-metabolizing enzymes.

• No mineral competition. It is not absorbed as an ion, so it does not compete with iron, zinc, calcium or copper for transporters the way those minerals compete with each other.

• The gap. Excipient interaction research is thin generally, and titanium dioxide has not been studied for effects on the absorption of the actives it coats. The absence of reported interactions reflects an absence of studies at least as much as an absence of effects.

• The one real interaction is regulatory. Directive 2009/35/EC restricts colors in EU human and veterinary medicines to those authorized as food additives. Delisting E171 would have removed it from medicines too, so Regulation (EU) 2022/63 kept it in Part B of Annex II for exclusive use in medicinal products.

Quality, Testing & Adulteration

This is the section where titanium dioxide differs from almost everything else covered in this archive, because there is no adulteration problem and no testing gap. There is a disclosure gap, and it is entirely fixable by the reader.

What you can verify for free. Presence or absence, from the other ingredients line, on every US supplement label, by law. No purchase, no lab, no certificate required. Compare that to standardized botanical extracts, where the marker compound percentage may be unverifiable without an assay.

What you cannot verify at all. The amount. No US supplement label discloses how much titanium dioxide a tablet contains, and no regulation requires it. The 1 percent by weight ceiling in 21 CFR 73.575 applies to the food, not to the coating, and is printed nowhere. Nor is particle size, polymorph, or supplier.

What a certificate of analysis would show. For the raw pigment, a supplier COA against the USP-NF titanium dioxide monograph or the 21 CFR 73.575 specification reports assay not less than 99.0 percent after drying 3 hours at 105 degrees Celsius, plus lead, arsenic, antimony and mercury against the 10, 1, 2 and 1 ppm limits. Finished-product COAs for supplements essentially never report coating excipients, because nobody asks.

Adulteration. Not a meaningful issue. Titanium dioxide is a cheap commodity produced at millions of tonnes per year, and there is no economic motive to cut it with anything.

What the market is already doing. Titanium dioxide-free coating systems are commercially available from the major coating suppliers, using calcium carbonate, rice starch, rice hull derivatives and calcium phosphate as opacifiers. Published coating work shows calcium carbonate reaching comparable lightness values at 40 percent pigment load with a 5 percent coating weight gain, the trade-offs being somewhat more coating material and a harder time protecting genuinely photolabile actives. DSLD shows the shift happening: titanium dioxide appeared on 4.82 percent of labels entered in 2019 and 2.16 percent of those entered in 2025, a fall of more than half in six years, with the sharpest drop between 2022 and 2023, from 3.31 percent to 2.15 percent.

Special Considerations

The jurisdictional split, stated precisely. Commission Regulation (EU) 2022/63 of 14 January 2022, published at OJ L 11, 18.1.2022, p. 1, amended Annexes II and III to Regulation (EC) No 1333/2008 to remove titanium dioxide. It entered into force on the twentieth day after publication, 7 February 2022. Article 2 allowed food containing E171 under the previous rules to be placed on the market for six months after that, until 7 August 2022, then to remain on sale until its date of minimum durability or use-by date. Recital 13 gives the reason for that transition period plainly: EFSA did not identify an immediate health concern. In the United States, 21 CFR 73.575 is unchanged.

Medicines were carved out. Article 3 of the same regulation required the Commission, after consulting the European Medicines Agency, to review within three years whether to keep or delete E171 for exclusive use as a color in medicinal products. That review reported in a Commission Staff Working Document of 6 August 2025, which found that roughly 91,000 human and 1,600 veterinary medicinal products in the EU contain titanium dioxide, that viable alternatives exist for fewer than 5 percent of them, that companies would need on the order of 7 to 12 years to reformulate their portfolios, and that a phaseout would very likely cause medicine shortages. E171 stays in EU medicines. A European can be prescribed a titanium dioxide coated tablet and cannot buy a titanium dioxide coated food supplement, because supplements are food and medicines are not.

France moved first. France suspended E171 in food by arrêté of 17 April 2019, effective 1 January 2020, under its EGalim food law, and has renewed the suspension annually since, most recently by arrêté of 12 December 2025.

Texas, from 2027. Texas SB 25 requires a warning label on packaged food containing any of 44 listed ingredients, and titanium dioxide is item 41 on that list. The required text reads: "WARNING: This product contains an ingredient that is not recommended for human consumption by the appropriate authority in Australia, Canada, the European Union, or the United Kingdom." It attaches to packaging developed or copyrighted on or after 1 January 2027, and the statute does not reach dietary supplements. For titanium dioxide the warning is carried by exactly one of those four jurisdictions, because Health Canada, FSANZ and the UK Committee on Toxicity all reviewed it and concluded otherwise.

Pregnancy. Prenatal products are the category where titanium dioxide is most concentrated in DSLD, 212 of 854 on-market labels aimed at pregnant and lactating users, 24.8 percent. EFSA found no reproductive or developmental toxicity up to 1,000 mg per kilogram body weight per day, so the reason to notice this number is not an established risk. It is that the population most likely to read a label carefully is the one most likely to encounter the ingredient.

Research Status & Evidence Quality

Strong Evidence For

• Very low oral absorption. EFSA put systemic availability at probably not greater than 0.5 percent, and Pele's human volunteer study, 7 subjects, 100 mg dose, is consistent with it.

• Presence of titanium dioxide particles in human liver and spleen. Heringa's 15 post-mortem samples settle that they are there.

• Excellent long-term performance of metallic titanium implants. Howe 2019, 18 studies, 96.4 percent 10-year implant survival.

• Absence of general toxicity signals in standard rodent testing up to 1,000 mg per kilogram body weight per day.

Moderate Evidence For

• Occupational inhalation hazard from respirable titanium dioxide dust, the basis for IARC Group 2B and the NIOSH limits of 2.4 and 0.3 mg/m3.

• Declining industry use in US supplements, measurable in DSLD label entries from 4.82 percent in 2019 to 2.16 percent in 2025.

Emerging / Preliminary Evidence For

• Intestinal immune and preneoplastic effects in rodents. Bettini 2017 is the anchor study and it is not confirmed. Blevins 2019, using dietary rather than drinking-water administration and larger group sizes, found nothing.

• Secondary genotoxicity through inflammation and reactive oxygen species rather than direct DNA binding. Plausible, incompletely demonstrated, and the pivot point of the entire regulatory disagreement.

Research Limitations

• No human cancer epidemiology on dietary titanium dioxide exists. Neither agency has that data, which is why both are reasoning from mechanism.

• Method sensitivity. JECFA, reaffirming ADI "not specified" on 24 November 2023, noted that the genotoxicity evidence is limited largely because standard test methods were not designed for nanoparticles.

• Test material heterogeneity. Many studies used P25, a photocatalytic grade, rather than E171. Weir's group made this argument in 2012 and it remains the strongest methodological criticism of the alarming literature.

• Funding and position matter. Warheit's 2024 defense of E171 in Frontiers in Toxicology, 6:1333746, argues EFSA made a manifest error, and discloses that the author is a former employee of DuPont de Nemours and Chemours, a titanium dioxide producer. Read it, but read the disclosure with it.

• Regulator alignment is not evidence of correctness, in either direction. EFSA, 25 March 2021, EFSA Journal 2021;19(5):6585, 130 pages: no longer safe. Health Canada, 14 July 2022: no conclusive scientific evidence of a concern. FSANZ: no evidence dietary exposure is a concern for human health. UK COT, August 2024: unlikely to be a risk at current UK dietary exposures. FDA: no concerns identified related to potential genotoxicity based on the data available. One against four is a count, not a finding.

Summary & Key Takeaways

Titanium is element 22, it has no nutritional role, and no legitimate supplement sells it. What carries it, without naming a price or a quantity, is the coating on 5,057 of 121,959 on-market American supplement products. The EU decided in January 2022 that it could not certify a safe daily intake for titanium dioxide as a food additive and removed it from the food supply by 7 August 2022. The FDA looked at substantially the same literature and left 21 CFR 73.575 in place. The petition to revoke it, filed on 14 April 2023 by the Environmental Defense Fund, the Center for Environmental Health, the Center for Food Safety, the Center for Science in the Public Interest and the Environmental Working Group under docket FDA-2023-C-1487, is still pending more than three years later.

Bottom Line

Titanium dioxide is in your supplement to make it look uniform, and for no other reason that reaches you. The strongest technical case for it, protecting light-sensitive vitamins, is met by other opacifiers already sold commercially. The safety question is genuinely open rather than settled in either direction, and it turns on whether an absence of reassurance should count as a reason to act.

Key Safety Points

• EFSA did not conclude that titanium dioxide causes cancer. It concluded that a concern for genotoxicity could not be ruled out and that an Acceptable Daily Intake could not be established. Those are claims about what is unknown, and anyone reporting them as a cancer finding is misreporting them.

• The one well-documented hazard is inhalation of powder at industrial concentrations, which has nothing to do with swallowing a coated tablet.

• Titanium implants are a separate subject with an excellent record, 96.4 percent survival at 10 years for dental implants, and nothing in the additive debate argues against them.

• No acute oral toxicity syndrome exists and no clinical test for dietary exposure is validated. Anyone selling a titanium test to assess supplement exposure is selling a number with no reference range.

Special Note

Almost every other issue in this archive ends with a trade-off. This one does not. The buyer gets nothing from titanium dioxide, so avoiding it costs nothing, and the information needed to avoid it is already printed on the bottle. That generalizes. The Supplement Facts panel is the regulated, quantified, marketed part of the label, and it is not where the interesting decisions are recorded. The unquantified paragraph underneath it is where a company writes down what it chose for its own convenience. Read that paragraph first on anything you take daily.